IntelliPharmaCeutics Announces 2012 Year End Results
2/1/2013 8:56:40 AM
More...
|
IntelliPharmaCeutics Announces Proposed Convertible Debenture Financing
1/7/2013 9:37:17 AM
More...
|
IntelliPharmaCeutics to Ring the NASDAQ Stock Market Opening Bell
10/26/2012 8:28:35 AM
More...
|
IntelliPharmaCeutics Announces Third Quarter 2012 Results
10/3/2012 9:52:46 AM
More...
|
IntelliPharmaCeutics Achieves a 2012 Goal by Filing Two ANDAs -- Generic Forms of Keppra XR® and Pristiq®
9/5/2012 9:27:27 AM
More...
|
IntelliPharmaCeutics Settles Patent Litigation With AstraZeneca PLC (AZN) Concerning Generic Seroquel XR®
7/31/2012 9:28:01 AM
More...
|
IntelliPharmaCeutics to Webcast, Live, at RetailInvestorConferences.com on July 12th
7/11/2012 11:42:40 AM
More...
|
IntelliPharmaCeutics Announces Second Quarter 2012 Results
7/5/2012 9:36:51 AM
More...
|
IntelliPharmaCeutics Meets a 2012 Goal for Abuse-Deterrent Oxycodone
5/1/2012 10:19:12 AM
More...
|
IntelliPharmaCeutics Announces First Quarter 2012 Results
4/13/2012 9:54:55 AM
More...
|
|